Results per Page:
Study supports effectiveness of RSV preventive antibody treatments for infants and provides new way to monitor viral resistance
Analysis published in Nature of more than 60,000 RSV sequences found resistance-associated variants to two monoclonal antibody treatments are rare and provides a roadmap to help guide the development of future prevention tools.
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
Going straight to the source in defense against infant RSV
New anti-idiotype antibody a first step in possible strategy to build infant immunity during vulnerable window